Literature DB >> 19669087

Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008.

E Terletskaia-Ladwig1, M Eggers, S Meier, M Leinmüller, F Schneider, M Schmid, M Enders.   

Abstract

BACKGROUND: In Germany, the cost for PCR diagnosis of influenza in ambulant patients was not covered by the national statutory health insurance system until 2008. Therefore, cell culture was the standard method applied for routine diagnosis. We have prospectively compared a 1-day rapid cell culture assay (RCA) with conventional cell culture (CCC) during the influenza seasons from 1997/1998 to 2007/2008 and with real-time PCR analysis during the influenza seasons 2003/2004 and 2006/2007. PATIENTS AND METHODS: This study is based on 4,262 respiratory samples obtained from ambulant patients between January 1998 and May 2008. The RCA was performed in microtiter plates that were stained with monoclonal antibodies to influenza virus A and B 16 h after inoculation.
RESULTS: A total of 1,221 specimens were found to be positive by the cell culture methods - 1,143 (93.6%) by the RCA and 1,012 (82.9%) by the CCC. The sensitivity of the RCA and CCC versus PCR was 75.4% (221/293) and 58% (170/293), respectively. The specificity of both cell culture assays versus PCR was 100%. Influenza A represented 79.3% of the cases diagnosed. An increased activity of influenza was observed between January and March, with the rate of influenza-positive cases being highest for kindergarten and school-aged children.
CONCLUSION: While PCR is the most sensitive assay for the diagnosis of influenza, the RCA can still be used for diagnosis and surveillance of this disease. Based on our findings and given the known fact that influenza antibodies reach a plateau 2-4 weeks after immunization, the optimal time for vaccination in Germany is from October through November. Kindergarten and school-aged children represent an important reservoir of infection. Consequently, routine immunization should be considered for this age group to prevent the spread of influenza.

Entities:  

Mesh:

Year:  2009        PMID: 19669087     DOI: 10.1007/s15010-009-8434-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  23 in total

1.  Experience with the rapid Directigen test for influenza.

Authors:  Paul J Drinka
Journal:  J Am Med Dir Assoc       Date:  2005-07-22       Impact factor: 4.669

Review 2.  Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.

Authors:  Nicola J Cooper; Alexander J Sutton; Keith R Abrams; Allan Wailoo; David Turner; Karl G Nicholson
Journal:  BMJ       Date:  2003-06-07

3.  Enhancing effect of centrifugation on isolation of influenza virus from clinical specimens.

Authors:  M Seno; Y Kanamoto; S Takao; N Takei; S Fukuda; H Umisa
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

4.  Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.

Authors:  M Zambon; J Hays; A Webster; R Newman; O Keene
Journal:  Arch Intern Med       Date:  2001-09-24

5.  Detection of influenza virus by centrifugal inoculation of MDCK cells and staining with monoclonal antibodies.

Authors:  R D Mills; K J Cain; G L Woods
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

6.  Sensitivity of diagnostic tests for influenza varies with the circulating strains.

Authors:  Adriana Weinberg; Christie J Mettenbrink; Dan Ye; Chin-Fen Yang
Journal:  J Clin Virol       Date:  2005-06       Impact factor: 3.168

Review 7.  Haemagglutination-inhibiting antibody to influenza virus.

Authors:  J C de Jong; A M Palache; W E P Beyer; G F Rimmelzwaan; A C M Boon; A D M E Osterhaus
Journal:  Dev Biol (Basel)       Date:  2003

8.  Rapid 24-well plate centrifugation assay for detection of influenza A virus in clinical specimens.

Authors:  G L Woods; A M Johnson
Journal:  J Virol Methods       Date:  1989 Apr-May       Impact factor: 2.014

9.  Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital.

Authors:  A M v d Hoeven; M Scholing; P C Wever; R Fijnheer; M Hermans; P M Schneeberger
Journal:  Infection       Date:  2007-04       Impact factor: 3.553

10.  Analysis of monthly isolation of respiratory viruses from children by cell culture using a microplate method: a two-year study from 2004 to 2005 in yamagata, Japan.

Authors:  Katsumi Mizuta; Chieko Abiko; Yoko Aoki; Asuka Suto; Hitoshi Hoshina; Tsutomu Itagaki; Noriko Katsushima; Yoko Matsuzaki; Seiji Hongo; Masahiro Noda; Hirokazu Kimura; Katsumi Ootani
Journal:  Jpn J Infect Dis       Date:  2008-05       Impact factor: 1.362

View more
  4 in total

1.  Clinical performance of three rapid diagnostic tests for influenza virus in nasopharyngeal specimens to detect novel swine-origin influenza viruses.

Authors:  V Pongthanapisith; C Sukasem; K Premchaiporn; C Srichantaratsamee; W Chantratita
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

2.  Comparing Influenza Positivity Rates by Real-Time RT-PCR, Elisa and Viral Culture Methods in Côte D'Ivoire, West Africa, in 2009.

Authors:  Ndahwouh Talla Nzussouo; Herve Adje Kadjo; Daouda Coulibaly; Euloge Ekaza; Bertin Kouakou; David Coulibaly N'Golo; Stefano Tempia; Richard Davis; Mireille Dosso; Mark Thompson
Journal:  Afr J Infect Dis       Date:  2013-08-09

3.  Comparison of the novel ResPlex III assay and existing techniques for the detection and subtyping of influenza virus during the influenza season 2006-2007.

Authors:  M Eggers; B Roth; B Schweiger; M Schmid; J-P Gregersen; M Enders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-20       Impact factor: 3.267

4.  Evaluation of the Becton Dickinson Rapid Influenza Diagnostic Tests in Outpatients in Germany during Seven Influenza Seasons.

Authors:  Maren Eggers; Martin Enders; Elena Terletskaia-Ladwig
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.